Lee Flowers insider trades: HCW Biologics (HCWB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lee reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | HCWB | ↑ Buy | 7,736 | $2.58 | $20K | Direct | Jul 31, 2026 (2d) |
| May 8, 2025 | HCWB | ↑ Buy | 962 | $26.00 | $25K | Direct | May 9, 2025 (1d) |
| Jun 8, 2023 | HCWB | ↑ Buy | 10,000 | $2.16 | $22K | Direct | Jun 9, 2023 (1d) |
| Aug 23, 2021 | HCWB | ↑ Buy | 13,458 | $4.03 | $54K | Direct | Aug 24, 2021 (1d) |
| Aug 19, 2021 | HCWB | ↑ Buy | 10,532 | $4.25 | $45K | Direct | Aug 23, 2021 (4d) |
| Jul 22, 2021 | HCWB | ↑ Buy | 31,250 | $8.00 | $250K | Direct | Jul 23, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HCWB insiders
Open-market trades in the last 12 months
About Lee Flowers's insider trades
Lee Flowers is SVP of Business Development at HCW Biologics (HCWB). Since Jul 22, 2021, Lee has reported 6 open-market purchases worth $416K and no sales on SEC Form 4. In the last 12 months: 1 buy ($20K).
Their filings also include option exercises (3 filings), grants and awards (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HCWB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.